Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases

Simona Fenizia,Melania Gaggini,Cristina Vassalle
DOI: https://doi.org/10.3390/ijms242317123
IF: 5.6
2023-12-05
International Journal of Molecular Sciences
Abstract:Sphingolipids (SLs) are structural, bioactive molecules with several key cellular roles, whereas 1,25-dihydroxyvitamin D (1,25(OH)D), the active form of vitamin D, is considered the major regulator of calcium homeostasis, although it also exerts other extraskeletal effects. Many studies reported the physiological connection between vitamin D and SLs, highlighting not only the effects of vitamin D on SL metabolism and signaling but also the influence of SLs on vitamin D levels and function, thus strongly suggesting a crosstalk between these molecules. After a brief description of 1,25(OH)D and SL metabolism, this review aims to discuss the preclinical and clinical evidence on the crosstalk between SLs and 1,25(OH)D, with a special focus on cardiometabolic diseases.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?